Extended therapy with [177Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer

被引：0
|
作者：
Nicolai Mader
Christina Nguyen Ngoc
Bilge Kirkgöze
Justus Baumgarten
Daniel Groener
Konrad Klimek
Christian Happel
Nikolaos Tselis
Felix K. H. Chun
Frank Grünwald
Amir Sabet
机构：
[1] University Hospital Frankfurt,Department of Nuclear Medicine
[2] University Hospital Frankfurt,Department of Radiation Oncology
[3] University Hospital Frankfurt,Department of Urology
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2023年 / 50卷
关键词：
Prostate-specific membrane antigen (PSMA); [; Lu]Lu-PSMA; Radioligand therapy (RLT); Extended treatment; Metastatic castration-resistant prostate cancer (mCRPC);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1811 / 1821
页数：10
相关论文
共 50 条
  • [21] LuCAB: A Phase I/II trial evaluating cabazitaxel in combination with [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Kostos, Louise
    Buteau, James P.
    Kong, Grace
    Opar, Petra
    Di Lulio, Juliana
    Fahey, Michael
    Fettke, Heidi
    Furic, Luc
    Hofman, Michael S.
    Azad, Arun
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 77 - 77
  • [22] Extended therapy with Lu-177-PSMA-617 in patients with high tumor load metastatic castration-resistant prostate cancer
    Mader, Nicolai
    Baumgarten, Justus
    Groner, Daniel
    Ngoc, Christina Nguyen
    Davis, Karen
    Banek, Severine
    Tselis, Nikolaos
    Happel, Christian
    Gruenwald, Frank
    Sabet, Amir
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [23] Prognostic Value of the De Ritis Ratio for Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Radioligand Therapy
    Gaal, Sebastian
    Huang, Kai
    Rogasch, Julian M. M.
    Jochens, Hans V.
    De Santis, Maria
    Erber, Barbara
    Amthauer, Holger
    CANCERS, 2023, 15 (20)
  • [24] Safety Analyses of the Phase 3 VISION Trial of [ 177 Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer
    Chi, Kim N.
    Armstrong, Andrew J.
    Krause, Bernd J.
    Herrmann, Ken
    Rahbar, Kambiz
    de Bono, Johann S.
    Adra, Nabil
    Garje, Rohan
    Michalski, Jeff M.
    Kempel, Mette M.
    Fizazi, Karim
    Morris, Michael J.
    Sartor, Oliver
    Brackman, Marcia
    Desilvio, Michelle
    Wilke, Celine
    Holder, Geoffrey
    Tagawa, Scott T.
    EUROPEAN UROLOGY, 2024, 85 (04) : 382 - 391
  • [25] Extended radioligand therapy with Lu-177-PSMA-617 in patients with advanced metastatic castration-resistant prostate cancer
    Mader, N.
    Baumgarten, J.
    Groener, D.
    Ngoc, C. Nguyen
    Davis, K.
    Banek, S.
    Tselis, N.
    Happel, C.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S489 - S489
  • [26] Tolerability of [177Lu]Lu-PSMA-617 by treatment exposure in patients with metastatic castration-resistant prostate cancer (mCRPC): A VISION study subgroup analysis.
    Tagawa, Scott T.
    Armstrong, Andrew J.
    Krause, Bernd J.
    Herrmann, Ken
    Rahbar, Kambiz
    De Bono, Johann S.
    Adra, Nabil
    Desilvio, Michelle
    Messmann, Richard
    Holder, Geoffrey
    Chi, Kim N.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] 177Lu-PSMA-617 Therapy in a Case of Metastatic Castration-Resistant Prostate Cancer
    Qu, Gengcuo
    Hua, Qingchu
    Li, Hongmei
    Zhang, Yu
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (02) : 152 - 153
  • [28] Building a predictive model for outcomes with [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer using VISION data: Preliminary results
    Herrmann, Ken
    Gafita, Andrei
    De Bono, Johann S.
    Sartor, A. Oliver
    Chi, Kim N.
    Krause, Bernd J.
    Rahbar, Kambiz
    Tagawa, Scott T.
    Czernin, Johannes
    El-Haddad, Ghassan
    Wong, Connie
    Zhang, Zhaojie
    Wilke, Celine
    Mirante, Osvaldo
    Morris, Michael J.
    Fizazi, Karim
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] Treatment of castration-resistant metastatic prostate cancer with [177Lu]PSMA radioligand
    Sundset, Rune
    Haugnes, Hege Sagstuen
    Perez, Alexander
    Engelsen, Ola
    Fosseide, Ida H. H.
    Castillejo, Miguel J.
    Bogsrud, Trond Velde
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2024, 144 (09)
  • [30] Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [177Lu]Lu- PSMA-617
    Muniz, Miguel
    Sartor, Oliver
    Orme, Jacob J.
    Koch, Regina M.
    Rosenow, Hana R.
    Mahmoud, Ahmed M.
    Andrews, Jack R.
    Kase, Adam M.
    Riaz, Irbaz B.
    Bilgin, Gokce Belge
    Thorpe, Matthew P.
    Kendi, A. Tuba
    Johnson, Geoffrey B.
    Ravi, Praful
    Kwon, Eugene D.
    Childs, Daniel S.
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (12) : 1932 - 1938
12345